Introduction
Anti-glutamic acid decarboxylase(GAD) are associated with various neurologic conditions, including stiff person syndrome, cerebellar ataxia, and limbic/extra-limbic encephalitis, seizure, cognitive impairment and behavioral disturbance(1–3). Growing evidence reveals the association of autoimmune meningoencephalitis with Covid-19 infection(4). Here we report a patient with anti-GAD65 autoimmune meningoencephalitis, post Covid-19 infection.